688617 惠泰医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)22.64430.43529.09320.21918.577
总资产报酬率 ROA (%)19.35324.24222.25216.89115.983
投入资产回报率 ROIC (%)22.16729.11827.32619.24217.499

边际利润分析
销售毛利率 (%)73.18972.31371.26671.20469.489
营业利润率 (%)38.05636.48436.38432.64726.850
息税前利润/营业总收入 (%)37.35835.50435.94232.27326.813
净利润/营业总收入 (%)32.92331.86031.64027.97323.513

收益指标分析
经营活动净收益/利润总额(%)95.78897.42989.58394.16481.429
价值变动净收益/利润总额(%)2.0651.7663.8795.33814.814
营业外收支净额/利润总额(%)-0.696-1.035-0.679-0.470-0.428

偿债能力分析
流动比率 (X)5.3823.9822.9863.7817.984
速动比率 (X)4.1052.9992.4282.9616.631
资产负债率 (%)12.23714.28723.74619.53811.029
带息债务/全部投入资本 (%)0.1961.5725.7414.1053.483
股东权益/带息债务 (%)50,086.5356,212.1551,622.8042,308.0372,744.078
股东权益/负债合计 (%)705.739590.892312.144405.440800.893
利息保障倍数 (X)-85.952-58.513-182.126-145.934346.318

营运能力分析
应收账款周转天数 (天)11.62410.8669.66112.01416.884
存货周转天数 (天)234.223228.878252.775309.035290.825